Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/104666

Beta release

Statistics of Mutational analysis of plasma DNA from patients (pts) in the phase III GRID study of regorafenib (REG) versus placebo (PL) in tyrosine kinase inhibitor (TKI)-refractory GIST: Correlating genotype with clinical outcomes
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0900
2024-1000